Abstract
Koh et al. show that imidazole propionate, a microbial metabolite, impairs the glucose-lowering effect of the anti-diabetic drug metformin and inhibits metformin-induced AMPK activation by activating p38γ/Akt/inhibitory AMPK serine phosphorylation. They further show that metformin action is restored by blocking imidazole propionate-activated p38γ.
Original language | English |
---|---|
Pages (from-to) | 643-653 |
Number of pages | 11 |
Journal | Cell Metabolism |
Volume | 32 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2020 Oct 6 |
Subject classification (UKÄ)
- Physiology and Anatomy
Free keywords
- AMPK
- diabetes
- imidazole propionate
- individual variations
- metformin
- microbial metabolites
- microbiota
- p38γ